Elekta AB ROE 2013-2025 | EKTAY
Current and historical return on equity (ROE) values for Elekta AB (EKTAY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elekta AB ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-10-31 | $0.03B | $0.90B | 3.27% |
| 2025-07-31 | $0.03B | $0.95B | 2.75% |
| 2025-04-30 | $0.02B | $0.84B | 2.29% |
| 2025-01-31 | $0.10B | $0.99B | 9.66% |
| 2024-10-31 | $0.10B | $1.01B | 9.46% |
| 2024-07-31 | $0.11B | $1.01B | 10.73% |
| 2024-04-30 | $0.12B | $1.01B | 12.38% |
| 2024-01-31 | $0.13B | $0.99B | 14.01% |
| 2023-10-31 | $0.13B | $0.94B | 13.41% |
| 2023-07-31 | $0.11B | $0.97B | 11.58% |
| 2023-04-30 | $0.09B | $0.93B | 10.01% |
| 2023-01-31 | $0.08B | $0.92B | 9.05% |
| 2022-10-31 | $0.09B | $0.85B | 9.30% |
| 2022-07-31 | $0.12B | $0.90B | 15.40% |
| 2022-04-30 | $0.13B | $1.00B | 16.09% |
| 2022-01-31 | $0.12B | $0.99B | 15.66% |
| 2021-10-31 | $0.14B | $0.22B | 17.41% |
| 2021-07-31 | $0.14B | $0.99B | 14.17% |
| 2021-04-30 | $0.14B | $0.94B | 15.63% |
| 2021-01-31 | $0.15B | $0.98B | 16.39% |
| 2020-10-31 | $0.14B | $0.91B | 16.23% |
| 2020-07-31 | $0.12B | $0.84B | 14.31% |
| 2020-04-30 | $0.11B | $0.84B | 13.51% |
| 2020-01-31 | $0.13B | $0.86B | 15.45% |
| 2019-10-31 | $0.12B | $0.81B | 14.63% |
| 2019-07-31 | $0.13B | $0.83B | 15.92% |
| 2019-04-30 | $0.13B | $0.86B | 16.54% |
| 2019-01-31 | $0.14B | $0.80B | 16.77% |
| 2018-10-31 | $0.15B | $0.77B | 18.19% |
| 2018-07-31 | $0.15B | $0.78B | 17.76% |
| 2018-04-30 | $0.13B | $0.96B | 15.62% |
| 2018-01-31 | $0.08B | $0.85B | 9.82% |
| 2017-10-31 | $0.05B | $0.83B | 6.12% |
| 2017-07-31 | $0.02B | $0.76B | 2.93% |
| 2017-04-30 | $0.01B | $0.78B | 1.85% |
| 2017-01-31 | $0.01B | $0.71B | 1.59% |
| 2016-10-31 | $0.01B | $0.77B | 0.92% |
| 2016-07-31 | $0.02B | $0.78B | 2.98% |
| 2016-04-30 | $0.02B | $0.76B | 1.92% |
| 2016-01-31 | $0.05B | $0.75B | 5.65% |
| 2015-10-31 | $0.06B | $0.79B | 7.73% |
| 2015-07-31 | $0.07B | $0.82B | 8.25% |
| 2015-04-30 | $0.07B | $0.90B | 7.43% |
| 2015-01-31 | $0.14B | $0.81B | 16.16% |
| 2014-10-31 | $0.15B | $0.83B | 16.59% |
| 2014-07-31 | $0.15B | $0.97B | 17.04% |
| 2014-04-30 | $0.17B | $0.96B | 19.94% |
| 2014-01-31 | $0.18B | $0.81B | 21.80% |
| 2013-10-31 | $0.19B | $0.78B | 24.06% |
| 2013-07-31 | $0.20B | $0.84B | 25.78% |
| 2013-04-30 | $0.20B | $0.84B | 27.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.400B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.567B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $189.075B | 73.97 |
| IDEXX Laboratories (IDXX) | United States | $54.780B | 54.40 |
| Edwards Lifesciences (EW) | United States | $48.432B | 32.47 |
| IQVIA Holdings (IQV) | United States | $39.797B | 22.19 |
| Alcon (ALC) | Switzerland | $39.104B | 26.35 |
| Mettler-Toledo (MTD) | United States | $28.673B | 33.55 |
| DexCom (DXCM) | United States | $27.586B | 38.03 |
| STERIS (STE) | Ireland | $25.321B | 26.14 |
| Waters (WAT) | United States | $22.858B | 30.23 |
| Coloplast (CLPBY) | Denmark | $18.998B | 32.42 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.345B | 0.00 |
| Penumbra (PEN) | United States | $13.920B | 97.92 |
| Globus Medical (GMED) | United States | $12.440B | 26.11 |
| Masimo (MASI) | United States | $7.665B | 24.56 |
| Glaukos (GKOS) | United States | $7.090B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.188B | 19.66 |
| TransMedics (TMDX) | United States | $4.850B | 57.46 |
| Teleflex (TFX) | United States | $4.434B | 7.07 |
| LivaNova (LIVN) | United Kingdom | $3.436B | 18.56 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Integer Holdings (ITGR) | United States | $2.984B | 14.01 |
| Alphatec Holdings (ATEC) | United States | $2.548B | 0.00 |
| Artivion (AORT) | United States | $2.061B | 94.59 |
| UFP Technologies (UFPT) | United States | $2.023B | 26.71 |
| Nihon Kohden (NHNKY) | Japan | $1.955B | 17.07 |
| PROCEPT BioRobotics (PRCT) | United States | $1.694B | 0.00 |
| AxoGen (AXGN) | United States | $1.470B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.389B | 0.00 |
| IRadimed (IRMD) | United States | $1.310B | 62.41 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.935B | 5.07 |
| Beta Bionics (BBNX) | United States | $0.811B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.671B | 38.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.550B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.548B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.540B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.463B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.458B | 12.63 |
| AngioDynamics (ANGO) | United States | $0.427B | 0.00 |
| RxSight (RXST) | United States | $0.397B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.360B | 59.94 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.237B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.195B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.126B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Venus Concept (VERO) | Canada | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.15 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |